Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment
- PMID: 35792231
- DOI: 10.1016/j.ijpharm.2022.121978
Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment
Abstract
Neurodegenerative diseases (NDs) are considered public health problem characterized by neural loss causing cognitive and behavioral impairments. It is currently possible to use drugs capable of controlling the symptoms caused by these diseases. However, treatment is not able to prevent neural loss. In addition, poor solubility, low bioavailability due to the inability for crossing the blood-brain barrier (BBB) are described as the main limitations of the treatment. Nanotechnology involves the development of nanoscale drug delivery systems and they have been employed to optimize therapeutics face to several diseases treatment. In light of this, this review describes the highlights on the fabrication of nanotechnology-based drug delivery systems emphasizing mesoporous silica, gold and silver nanoparticles (MSNs, AuNPs and AgNPs, respectively) and their biological behavior for the treatment of Alzheimer's and Parkinson diseases (ADs and PDs, respectively).
Keywords: Drug delivery systems; Mesoporous silica nanoparticles; Neurodegenerative diseases treatment; Silver and gold nanoparticles; Smart nanocarriers.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.ACS Appl Mater Interfaces. 2014 Aug 13;6(15):12038-45. doi: 10.1021/am5026424. Epub 2014 Jul 29. ACS Appl Mater Interfaces. 2014. PMID: 25050635
-
Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer's disease treatment.Acta Biomater. 2016 Dec;46:177-190. doi: 10.1016/j.actbio.2016.09.010. Epub 2016 Sep 9. Acta Biomater. 2016. PMID: 27619837
-
DNA-templated in situ growth of silver nanoparticles on mesoporous silica nanospheres for smart intracellular GSH-controlled release.Chem Commun (Camb). 2015 Apr 18;51(30):6544-7. doi: 10.1039/c5cc00557d. Chem Commun (Camb). 2015. PMID: 25765340
-
A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.Recent Pat Drug Deliv Formul. 2020;14(2):126-144. doi: 10.2174/1872211314666200914155051. Recent Pat Drug Deliv Formul. 2020. PMID: 32928094 Review.
-
Mesoporous silica nanoparticles in drug delivery and biomedical applications.Nanomedicine. 2015 Feb;11(2):313-27. doi: 10.1016/j.nano.2014.09.014. Epub 2014 Nov 13. Nanomedicine. 2015. PMID: 25461284 Review.
Cited by
-
The subacute toxicity and underlying mechanisms of biomimetic mesoporous polydopamine nanoparticles.Part Fibre Toxicol. 2023 Oct 8;20(1):38. doi: 10.1186/s12989-023-00548-4. Part Fibre Toxicol. 2023. PMID: 37807046 Free PMC article.
-
Breaking barriers: The potential of nanosystems in antituberculosis therapy.Bioact Mater. 2024 May 17;39:106-134. doi: 10.1016/j.bioactmat.2024.05.013. eCollection 2024 Sep. Bioact Mater. 2024. PMID: 38783925 Free PMC article. Review.
-
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments.Ibrain. 2023 Aug 14;9(3):298-315. doi: 10.1002/ibra.12126. eCollection 2023 Fall. Ibrain. 2023. PMID: 37786760 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
